CERo Therapeutics Warrants
CEROW
CEROW was delisted on the 30th of October, 2025.
26 hedge funds and large institutions have $45.7K invested in CERo Therapeutics Warrants in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 3 reducing their positions, and 2 closing their positions.
60% more capital invested
Capital invested by funds: $28.6K → $45.7K (+$17.1K)
0.12% more ownership
Funds ownership: 2.13% → 2.26% (+0.12%)
0% more funds holding
Funds holding: 26 → 26 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.72K |
| 2 |
PA
Parallel Advisors
San Francisco,
California
|
+$705 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
-$804 |
| 2 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$25 |
| 3 |
CS
Clear Street
New York
|
-$11 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$4 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
26
Ancora Advisors
Cleveland,
Ohio
| $36 | – | – | – |
|
|
27
Bank of America
Charlotte,
North Carolina
| – | -$4 | -500 | Closed |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | -$1 | -87 | Closed |
|
CEROW Hedge Fund Activity: Q1 2025 in Review
26 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics Warrants (CEROW) for Q1 2025, worth a combined $45.7K — up 60% from $28.6K a quarter earlier.
Fund positioning in CEROW was balanced in Q1 2025: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $2.72K. The largest seller was Walleye Trading, cutting an estimated $804.
- 26 institutional investors held CERo Therapeutics Warrants (CEROW) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $45.7K of CERo Therapeutics Warrants stock for Q1 2025, up 60% quarter-over-quarter.
- 2 funds opened new CERo Therapeutics Warrants positions in Q1 2025 and 2 closed out, a net change of 0 holders.
- The largest CERo Therapeutics Warrants buyer in Q1 2025 was Susquehanna International Group, an estimated $2.72K added.
- The largest CERo Therapeutics Warrants seller in Q1 2025 was Walleye Trading, an estimated $804 sold.
Based on aggregated 13F filings for Q1 2025.